Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |
mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.01 |
mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.01 |
mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.087 | 0.01 |
mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.01 |
mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.1 | 0.01 |
mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.082 | 0.01 |